The ICD-10 code for Kasabach-Merritt syndrome is D18.0. This code is used to classify and document this rare condition characterized by the presence of a vascular tumor with severe thrombocytopenia. In the previous ICD-9 coding system, Kasabach-Merritt syndrome was classified under 287.39. It is important to consult with a healthcare professional for accurate diagnosis and coding.
Kasabach-Merritt syndrome is a rare but serious condition characterized by the development of vascular tumors, known as hemangiomas, accompanied by severe thrombocytopenia (low platelet count) and coagulopathy (abnormal blood clotting). While ICD-10 codes are alphanumeric codes used to classify diseases and medical conditions, ICD-9 codes were used prior to the implementation of ICD-10.
The ICD-10 code for Kasabach-Merritt syndrome is D18.09. This code falls under the category of "Hemangioma and lymphangioma, any site." It is important to note that the ICD-10 code captures the specific condition, but additional codes may be required to describe the associated symptoms or complications.
On the other hand, the corresponding ICD-9 code for Kasabach-Merritt syndrome is 228.09. The ICD-9 code system was used until September 30, 2015, when it was replaced by the ICD-10 code system. The ICD-9 code similarly falls under the category of "Benign neoplasm of other and unspecified sites."
These codes are utilized by healthcare professionals for accurate diagnosis, billing purposes, and statistical analysis, ensuring effective communication and understanding among medical providers.